Market Tracker

10/24 6:05pm ET

Dyax Corp (NASDAQ:DYAX)

10.81
Data as of Oct 24
 +0.07 / +0.65%
Today’s Change
6.05
Today|||52-Week Range
11.01
+43.46%
Year-to-Date
No recent news for Dyax Corp.

Today’s Trading

Previous close10.74
Today’s open10.73
Day’s range10.64 - 10.91
Volume1,121,118
Average volume (3 months)975,312
Market cap$1.5B
Dividend yield--
Data as of 3:59pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)+13.33%
Earnings growth (this year)+28.02%
Earnings growth (next 5 years)+18.64%
Revenue growth (last year)-1.32%
P/E ratioNM
Price/Sales15.17
Price/Book49.98

Competitors

 Today’s
change
Today’s
% change
KERXKeryx Biopharmaceuti...+0.17+1.03%
NKTRNektar Therapeutics-0.10-0.75%
ABCOAdvisory Board Co+1.00+2.01%
ARIAARIAD Pharmaceutical...+0.12+2.10%
Data as of 3:59pm ET, 10/24/2014

Financials

Next reporting dateOctober 29, 2014
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$53.9M
Annual profit (last year)-$27.8M
Net profit margin-51.51%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gustav A. Christensen
Chief Financial Officer &
Executive Vice President
George V. Migausky
Corporate headquarters
Burlington, Massachusetts

Forecasts